7-Oct-2024
Investor webinar: Neuren continues PMS Phase 3 preparations following positive FDA meeting
19-Aug-2024
Investor roadshow presentation, 19 August 2024
9-Aug-2024
Investor webinar: NNZ-2591 Angelman syndrome Phase 2 trial top-line results
9-Aug-2024
NNZ-2591 Angelman top-line results presentation
29-May-2024
Corporate Presentation, 29 May 2024
28-May-2024
AGM webcast, 28 May 2024
28-May-2024
AGM Chair Address & CEO Presentation
27-May-2024
Investor webinar - Pitt Hopkins Phase 2 results, 27 May 2024
27-May-2024
Pitt Hopkins Phase 2 results presentation, 27 May 2024
15-May-2024
Investor presentation, 15 May 2024
1-Mar-2024
Investor webinar, 29 February 2024
18-Dec-2023
Investor web conference, 18 December 2023
18-Dec-2023
Investor presentation, 18 December 2023
8-Nov-2023
Investor presentation, 8 November 2023
29-Aug-2023
Investor web conference, 28 August 2023
28-Aug-2023
Investor presentation, 28 August 2023
14-Jul-2023
Investor web conference, 14 July 2023
5-Jun-2023
Jefferies Global Healthcare Conference, 8 June 2023
2-Jun-2023
AGM webcast, 30 May 2023
30-May-2023
AGM Chair Address & CEO Presentation
17-Mar-2023
Investor webinar, 14 March 2023
7-Dec-2022
MST Financial: Late Stage Biotech Forum, 30 Nov 2022
29-Nov-2022
Bell Potter Healthcare Conference, 8 Nov 2022
30-May-2022
AGM Chairman's Address & CEO Presentation
25-Feb-2022
Investor webinar, 25 February 2022
29-Jun-2021
MST Access Australian Micro & Small Caps Conference 2021 15 June 2021